Kiadis and GCRBC team up to offer universal donor starting material

Date: 2020-09-29   Author: Saipriya Iyer  Category: #news

Kiadis and GCRBC team up to offer universal donor starting material

Kiadis Pharma, a renowned Dutch pharmaceutical company that makes NK cell based medicines to treat critical life threatening diseases, and the GCRBC (Gulf Coast Regional Blood Center), a US based blood components supplier to more than 170 healthcare facilities and hospitals, have reportedly announced a new partnership according to which GCRBC would provide universal donor starting material to produce Kiadis’ off-the-shelf K-Natural Killer cell therapies in the U.S.

The off-the-shelf K-NK platform is based on the NK cells received from unique universal donors. This partnership would supply the pharmaceutical company with a consistent universal donor starting material supply that is required for research and development as well as clinical supply. The firm is creating multiple K-NK programs that need universal donor starting material. 

Kiadis CEO, Arthur Lahr stated that the company’s partnership with GCRBH grants it access to the broad GCRBH donor network to recognize universal donors using the firm’s selection analytics and proprietary algorithm. 

Lahr further added that the company collects donor immune cells as source material to develop off-the-shelf K-NK cells. The new partnership helps the company maintain a consistent supply of starting material for its K-NK cell therapy programs.

Cellular Life Solutions Director at GCRBC, Hope Guidry-Groves stated that the company aims to collaborate with the community to effectively help sustain and save lives by ensuring a safe and secure supply of biotherapies, blood, and other relevant services. 

Guidry-Groves further added that with the company’s excellent history as well as proven expertise in the field, it can increase the treatment options to patients with the help of  advanced blood therapies. The company, by helping researchers identify and locate eligible and willing blood donors for their specialized collections, is doing its part to bring a new ray of hope for patients.

Source credit:

About Author

Saipriya Iyer linkdin-boxtwitter

Saipriya Iyer

Saipriya Iyer currently works as a content developer for AlgosOnline. A computer engineer by profession, she ventured into the field of writing for the love of playing with words. Having had a previous experience of 3 years under her belt, she has dabbled with website...

Read More

Post Recommendents

Antenatal Screening Market Share, By Product Analysis, Application, End-Use, Regional Outlook, Competitive Strategies & Forecast up to 2028

Author: Ashwin Naphade

Global Antenatal Screening Market, 2022-2028 Research Report provides crucial statistics on the market status of the Global Antenatal Screening manufacturers and is a respected source of guidance and direction for companies and individuals interes...

Pediatric Vitrectomy Market Size | Global Industry Analysis, Segments, Top Key Players, Drivers and Trends to 2028

Author: Ashwin Naphade

Global Pediatric Vitrectomy market report provides major statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

The Pediatric Vitrectomy market repor...

Legionnaire Disease Testing Market Comprehensive Analysis, Share, Growth Forecast from 2022 to 2028c

Author: Ashwin Naphade

This report studies the Global Legionnaire Disease Testing market status and outlook of global and major regions, from angles of players, regions, product types and end industries; this report analyzes the top players in global and major regions, ...